FDA official logo
GSRS logo
PFDA official logo

DABIGATRAN ETEXILATE

  • UNII: 2E18WX195X
  • Formula: C34H41N7O5
  • Preferred Substance Name: DABIGATRAN ETEXILATE
  • InChIKey: KSGXQBZTULBEEQ-UHFFFAOYSA-N

  • 211915-06-9
  • .BETA.-ALANINE, N-((2-(((4-((((HEXYLOXY)CARBONYL)AMINO)IMINOMETHYL)PHENYL)AMINO)METHYL)-1-METHYL-1H-BENZIMIDAZOL-5-YL)CARBONYL)-N-2-PYRIDINYL-, ETHYL ESTER
  • BIBR 1048
  • BIBR 1048 BS RS1
  • BIBR-1048
  • BIBR-1048-BS-RS1
  • DABIGATRAN ETEXILATE [INN]
  • DABIGATRAN ETEXILATE [MART.]
  • DABIGATRAN ETEXILATE [MI]
  • DABIGATRAN ETEXILATE [USAN]
  • DABIGATRAN ETEXILATE [VANDF]
  • DABIGATRAN ETEXILATE [WHO-DD]
  • DABIGATRAN ETEXILATE METHANESULFONATE [JAN]
  • ETHYL 3-(((2-(((4-((((HEXYLOXY)CARBONYL)AMINO)IMINOMETHYL)PHENYL)AMINO)METHYL)-1-METHYL-1H-BENZIMIDAZOL-5-YL)CARBONYL)(PYRIDIN-2-YL)AMINO)PROPANOATE
  • ETHYL 3-(((2-(((4-(((HEXYLOXY)CARBONYL)CARBAMIMIDOYL)PHENYL)AMINO)METHYL)-1-METHYL-1H-BENZIMIDAZOL-5-YL)CARBONYL)(PYRIDIN-2-YL)AMINO)PROPANOATE
  • PRADAXA
  • PRADAXA (DABIGATRAN ETEXILATE)
  • PRAZAXA

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.